Compare Boston Scientific Corporation (BSX) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Cassava Sciences Inc — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Boston Scientific Corporation is far larger — about 1496.5× Cassava Sciences Inc's market cap, and Boston Scientific Corporation is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| BSX | FLNA | |
|---|---|---|
Market Cap | $71.46B | $47.75M |
Sector | Health | Health |
52-Week High | $108.14 | $4.64 |
52-Week Low | $42.63 | $0.87 |
Enterprise Value | $83.55B | -$34.93M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
